Company intelligence / Profile preview

BOHE Angel Fund

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~7
Development stage: Other

Overview

BOHE Angel Fund is China's first angel fund focused on early-stage investments in innovative biotechnologies and healthcare globally. It has invested in over 30 biopharmaceuticals, established incubation centers bio2 (Beijing) and adock (Suzhou), and manages funds including an initial $60M fund and a follow-on $75M fund.

Industry: Investors

Beyond the preview

Go deeper on BOHE Angel Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BOHE Angel Fund.

Explore the full profile